Xenetic Biosciences, Inc. Quarterly Operating Income (Loss) in USD from Q4 2011 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Xenetic Biosciences, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q4 2011 to Q2 2024.
  • Xenetic Biosciences, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$1.34M, a 11.6% decline year-over-year.
  • Xenetic Biosciences, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$5.01M, a 10.7% decline year-over-year.
  • Xenetic Biosciences, Inc. annual Operating Income (Loss) for 2023 was -$4.52M, a 32.8% increase from 2022.
  • Xenetic Biosciences, Inc. annual Operating Income (Loss) for 2022 was -$6.72M, a 16.9% decline from 2021.
  • Xenetic Biosciences, Inc. annual Operating Income (Loss) for 2021 was -$5.75M, a 58.8% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$5.01M -$1.34M -$139K -11.6% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 -$4.87M -$1.27M -$353K -38.6% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 -$4.52M -$1.26M +$308K +19.7% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-21
Q3 2023 -$4.82M -$1.15M -$299K -35.3% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 -$4.52M -$1.2M +$1.49M +55.4% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 -$6.01M -$915K +$705K +43.5% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 -$6.72M -$1.56M +$311K +16.6% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-21
Q3 2022 -$7.03M -$848K +$528K +38.4% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$7.56M -$2.69M -$1.56M -138% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 -$6M -$1.62M -$251K -18.3% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 -$5.75M -$1.87M -$654K -53.6% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-22
Q3 2021 -$5.09M -$1.38M +$9.13M +86.9% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 -$14.2M -$1.13M -$145K -14.8% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 -$14.1M -$1.37M -$138K -11.2% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 -$13.9M -$1.22M +$14.8K +1.2% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-22
Q3 2020 -$14M -$10.5M -$1.56M -17.4% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 -$12.4M -$982K +$396K +28.7% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 -$12.8M -$1.23M +$96.4K +7.26% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-11
Q4 2019 -$12.9M -$1.23M +$405K +24.7% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-16
Q3 2019 -$13.3M -$8.95M -$7.13M -393% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 -$6.16M -$1.38M +$615K +30.9% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-12
Q1 2019 -$6.78M -$1.33M +$501K +27.4% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-14
Q4 2018 -$7.28M -$1.64M -$6.07M -137% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-26
Q3 2018 -$1.21M -$1.81M +$426K +19% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 -$1.63M -$1.99M +$910K +31.3% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
Q1 2018 -$2.54M -$1.83M +$1.03M +36% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-13
Q4 2017 -$3.57M $4.43M +$4.5M Oct 1, 2017 Dec 31, 2017 10-K 2019-03-29
Q3 2017 -$8.06M -$2.24M +$11.1K +0.49% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-09
Q2 2017 -$8.08M -$2.9M +$40.4M +93.3% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-10
Q1 2017 -$48.4M -$2.86M -$1M -54.2% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q4 2016 -$47.4M -$64.4K +$2.63M +97.6% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-30
Q3 2016 -$50.1M -$2.25M +$1.55M +40.8% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-14
Q2 2016 -$51.6M -$43.3M -$41.9M -3083% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-14
Q1 2016 -$9.7M -$1.85M +$119K +6.02% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15
Q4 2015 -$9.82M -$2.69M +$1.53M +36.2% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-31
Q3 2015 -$11.3M -$3.8M -$692K -22.3% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-14
Q2 2015 -$10.7M -$1.36M +$1.28M +48.5% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-15
Q1 2015 -$11.9M -$1.97M +$989K +33.4% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-16
Q4 2014 -$12.9M -$4.22M -$4.14M -5394% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-30
Q3 2014 -$8.78M -$3.11M -$578K -22.9% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-16
Q2 2014 -$8.21M -$2.64M -$1.61M -156% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-19
Q1 2014 -$6.6M -$2.96M -$1.57M -113% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-20
Q4 2013 -$5.03M -$76.8K -$65.5K -580% Sep 1, 2013 Nov 30, 2013 10-Q 2014-01-10
Q3 2013 -$4.96M -$2.53M Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-14
Q2 2013 -$1.03M -$997K -2798% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-14
Q1 2013 -$1.39M -$1.36M -5218% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-20
Q4 2012 -$11.3K +$3.54K +23.9% Sep 1, 2012 Nov 30, 2012 10-Q 2014-01-10
Q2 2012 -$35.6K Mar 1, 2012 May 31, 2012 10-Q 2013-07-17
Q1 2012 -$26.1K Dec 1, 2011 Feb 29, 2012 10-Q 2013-04-22
Q4 2011 -$14.8K Sep 1, 2011 Nov 30, 2011 10-Q 2013-01-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.